Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series.

Autor: Cohet C; Global Epidemiology, GSK Vaccines, Wavre, Belgium., Haguinet F; Global Epidemiology, GSK Vaccines, Wavre, Belgium., Dos Santos G; Business & Decision Life Sciences, Brussels, Belgium (on behalf of GSK Vaccines)., Webb D; Department of R&D, GSK, Uxbridge, Middlesex, UK., Logie J; Department of R&D, GSK, Uxbridge, Middlesex, UK., Lc Ferreira G; Global Epidemiology, GSK Vaccines, Wavre, Belgium., Rosillon D; Global Epidemiology, GSK Vaccines, Wavre, Belgium., Shinde V; Global Epidemiology, GSK Vaccines, Wavre, Belgium.

Publikováno v: BMJ open [BMJ Open] 2016 Jan 28; Vol. 6 (1), pp. e009264. Date of Electronic Publication: 2016 Jan 28.